In this regard, the role of IP3R in VSMC contractility in vivo was recently highlighted in a conditional triple knockout mouse, where the agonist-mediated vascular constriction was attenuated together with a lack of development of hypertension in response to chronic angiotensin infusion (Lin et al., 2016). The gene discussed is ITPR1; the disease is hypertensive disorder.